Follow Cold Wallet’s $5.9M presale growth backed by real users and cashback utility, while the Litecoin (LTC) price surge ...

In 2025, the crypto market is showing fresh signs of life, and for those aiming to grow their holdings, identifying the best ...

An update from MEI Pharma ( (MEIP) ) is now available.

Litecoin ETF approval talk grows as institutional interest rises, fueled by regulatory clarity and LTC’s increasing role in ...

In August 2025, H. Lee Moffitt Cancer Center and Research Institute announced a study is to establish the safety and efficacy ...

With half-year industry financings down 59% from last year, and a U.S. administration supportive of cryptocurrencies, ...

EDT MEI Pharma (MEIP) files to sell 25.3M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ...

MEI Pharma buys 929,548 LTC worth $110M, making it the first US public company with a Litecoin reserve and boosting optimism ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...